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1. Introduction 
From the recognition by Ivanovski in 1892 that tobacco mosaic disease is caused and transmitted by 
fine pore filtrates [1], viruses have been isolated, characterized, identified and studied from animals, 
plants, protists, bacteria and even other viruses [2,3]. As human and global public health pathogens 
that can be highly contagious and have devastating morbidity and mortality consequences, viruses are 
the focus of much research. The difficult challenge has been to define and study a miniscule “being” 
with the appropriate tools. In the past, these tools often provided only low-resolution views. A first 
approach to studying an unknown virus is to know exactly its identity, and to place it into context of 
other related and non-related viruses. For human and public health, this is important as the identity 
may provide a course of action to limit the effects of the pathogen. 
Virus identification, characterization and taxonomy are necessarily based on the “best-available” 
methodology and technology. The “best-available” may not be the ideal method. In the past as well as 
currently, virus attributes used for identification include measurements of the physical viral structure; 
biological, biochemical and clinical observations; pathogenic properties, antibody recognition of 
capsid proteins (immunochemistry); and the physical genetic material (genome), including the 
particular form of genome, genome hybridization and restriction enzyme digestion patterns [2]. 
Technology is now providing a much better alternative with the development of recombinant DNA 
protocols and DNA sequencing methods. 
The development of DNA sequencing methodologies, particularly the Sanger dideoxynucleotide 
chain terminator-based chemistry, has provided the ultimate highest resolution data possible: the 
primary genome sequence. The original validation of this method by sequencing a DNA virus   
(phi-X174; 5.4 kb) [4] has led to a continuing cycle of data acquisition and analysis in conjunction 
with technology development, with immediate impacts beyond “mere” viruses. Since 1977, with the 
tsunami of sequence data, along with rising scientific and public interest, the focus and resources have 




shifted to the much larger and “sexier” genomes, particularly the human genome and bacterial 
pathogens. On a smaller scale (seiche) however, viral genomes are being sequenced and studied as 
well, but with less fanfare. Recently available resources allow for a larger genomic view of viruses, 
particularly as populations rather than single entities. For example, the National Institute of Allergy 
and Infectious Disease (NIAID) and the National Institutes of Health (NIH), through the funding of the 
Genome Sequencing Center (GSC) for Infectious Diseases at the J. Craig Venter Institute (JCVI), have 
recently approved “white papers” proposing for the large-scale genomic sampling of several groups of 
viruses: adenovirus, influenza, norovirus, rotavirus, coronavirus, arbovirus and paramyxovirus. 
Rhinoviruses, as a group, were recently analyzed in such a format allowing for a global 
examination  [5] and more genomes in this family are being sequenced. Development of next 
generation DNA sequencing technology is providing an additional impetus, given “faster, cheaper” 
and hopefully higher quality data. 
From the first virus genome sequence completed (MS2; 3.6 kb) [6] to that of the recent largest virus 
(mimivirus; 1.2 Mb) [7], the viral genome and its analysis have revealed high-resolution details of the 
molecular basis of a particular biological system, along with unexpected and surprising details.   
As viruses, again, are important health concerns and are also past and current “model organisms”,  
an “umbrella effect” is taking place, following the collection of genome sequence data. In this 
scenario, associated viral genome-specific bioinformatic tools are being developed, data sets and 
databases established, biotechnological tools and applications implemented, and new policies and 
standards established- all resulting from virus genome sequence data. All of these are presented, as 
representations, in this special issue, reflecting the continued and growing importance of viral 
genomics and bioinformatics. 
1.1. Genomics of Select Virus Families 
Although, in general, large data sets of related viral genomes from a family are just being 
assembled, there are available sets of genomes from members of certain virus families that are of 
recent and critical interest in the context of human and public health issues. Many of these data sets 
have either been recently assembled and reported, such as rhinovirus [5], or have been reviewed 
recently, for example, rhabdoviruses [8], papillomavirus [9] and human immunodeficiency virus (HIV) 
[10]. The recent publication of these and other similar genomes preclude their inclusion in this special 
issue. 
Rather than attempting to provide a comprehensive survey of many virus families with multiple 
genomes sequenced and analyzed, a goal of this special issue is to provide a sampling and a range of 
the virus families that have been and are of importance such that multiple genomes have been 
sequenced and analyzed using bioinformatic methods. From these contributions, one will see that 
genomics and bioinformatics are intertwined. At one end of the spectrum are human adenoviruses, 
which contain DNA genomes of 35 kb. Once considered “large genome” viruses, these are provided in 
contrast to the much larger genomes found amongst the Iridoviridae, with DNA genomes of 106 kb. 
Eaton et al. reviews these. In addition, Hendrickson et al. examines the Poxviridae genomes, which 
range from 130 to 375 kb. For comparison, Woo et al., reports on the coronaviruses, with the largest 




viral genomics and bioinformatics in monitoring and identifying global pathogens rapidly and 
effectively, allowing for measures to be taken. The pathogen responsible for causing a novel highly 
contagious respiratory disease in Hong Kong (2002-2003), severe acute respiratory syndrome (SARS), 
was identified as a SARS-related coronavirus by a microarray assay that made use of unique genome 
signature sequences [11]. A possible origin for this emergent pathogen is presented by Woo et al., 
using molecular clock analysis to show that the most recent common ancestor of human/civet   
SARS-related coronovirus appeared in the period between 1999-2002, just preceding the outbreak. 
They also note recombination between different strains of coronaviruses. In general, genome 
recombination is a molecular pathway leading to new strains and emergent pathogens, as demonstrated 
recently in the human adenoviruses [12,13]. 
Torres et al.,  in their contribution summarizing the growing number of human adenoviruses 
genomes, note that there is a “revolution in viral genomics”, exemplified by the bioinformatic analysis 
of the genomes and an initiative to change the long-standing gold standards for taxonomy and 
nomenclature. A paradigm change, along with a genomics and bioinformatics-based algorithm, is 
proposed to use the whole genome attributes, including phylogenomics and compelling changes in the 
strain’s biology and pathogenicity. This calls for utilizing 100% of the primary sequence data rather 
than the past use of immunochemical methods, such as serum neutralization, that probed the limited 
and often murky three-dimensional protein array (epitope) that represents an indirect interpretation of 
the primary sequence data, the tertiary sequence. As illustrated in a figure by Torres et al., for the 
human adenoviruses, the hexon-specific loop 1 epitope represents only 2.6% of the genome 
sequence [13]. Although a genome-based paradigm is surprisingly controversial and has detractors, 
this approach, along with a genome-based algorithm, has already been implemented in the 
papillomaviruses (PV) since 2004 [8]. An interesting, but illogical and amusing, comment by 
detractors of this “revolution in human adenovirus nomenclature” is “there will be too many numbers 
(new types)”. As noted by Torres et al., there are currently 55 human adenovirus types accepted by 
peer review; this is less than one-third of the 189 PV types recognized currently [9]. 
Hendrickson et al. provide a contribution examining the Poxviridae genomes. Members of this 
family are highly successful pathogens that infect a range of hosts, and cause may diseases in humans, 
including smallpox. They are also of interest as naturally occurring pathogens (monkeypox) and 
potential biothreat agents (smallpox-related). A collection of genomes allows an understanding of the 
orthologous genes (core genes) shared across this diverse group of viruses. As an example of the 
differences between genomes of viruses and other organisms and of the ironic complexity of analyzing 
“simple smaller” viral genomes, a newly developed poxvirus-specific computational tool was used to 
predict accurate gene sets. This provided a view of reductive evolution, where the reduction in the core 
gene set, that is, gene loss, plays a proposed critical role in speciation and serves to limit emergent 
viruses to particular niches. Eaton et al., in their survey of Iridoviridae, also examined the concept of 
core genes within the diverse members of that family. They also note, in addition, that individual 
genomes contain sets of unique repetitive sequences. 




1.2. Bioinformatics and Computational Analysis Tools 
As noted earlier, viral genomes differ from other organism genomes in complexity, despite their 
generally smaller sizes and presumed “simplicity”. For example, one problem is that the smaller size of 
the genome dictates a higher density of gene coding, with all six reading frames utilized. Coding 
regions frequently overlap. Another problem is that mRNA transcripts often yield multiple spliced 
products. Some of the exons may be located far apart and may contain very short coding regions. 
These complicate the analysis of viral genomes and may be barriers to comparative analysis especially 
if genome annotation standards are not in place. Software tools, such as automated annotation, 
developed for non-virus genomes may not be transferable directly to the analysis of virus genomes. 
These issues are critical in virus genomics and bioinformatics. The contributions in this special issue 
include virus-specific computational tools. Mentioned earlier, Hendrickson et al. provide a newly 
developed poxvirus-specific computational tool for predicting accurate gene sets. Eaton et al. noted 
that individual Iridoviridae genomes contain sets of unique repetitive sequences. These “repeats [,] 
common to more than one virus [,] were also identified and changes in copy number between these 
repeats may provide a simple method to differentiate between very closely related virus strains”. 
Specific software to take advantage of the general nature of unique repetitive sequences in viral 
genomes was presented in a contribution by Sadeque et al. This is an online software tool developed 
for identifying highly conserved DNA sequences. Again, these conserved sequences may be used to 
identify specific strains and pathogens, and may be used for tracking a specific strain in outbreaks or 
for molecular evolution studies. These are also unique genome signatures that can be used as a 
surveillance or diagnostic tool, such as the ones used to populate an Affymetrix microarray chip 
developed for respiratory pathogens [14]. 
Both Eaton et al., examining Iridoviridae, and Hendrickson et al., examining Poxviridae, note the 
importance of core gene sets amongst the viruses in their contributions. The wealth of genomes, 
particularly the bacterial ones originally, has enabled a broader view and analysis of the components 
that are required, presumably being conserved within a family of genomes [15]. This has led to the 
concept of a “pan-genome” that comprises a “core” set and a “dispensable” set of genes. The 
dispensable set presumably allows a unique strain to occupy a specific niche. CoreGenes is an   
“on-the-fly” web-accessible software tool designed originally (2002) to survey a group of viruses for 
determining a core set of genes; recently it has been upgraded [16] to provide features desired for the 
display of an in silico proteome used for reclassifying the bacteriophage genomes [17]. Recently 
another version of this computational tool has been published, noting the division of the pan-genome 
into a “core” and an “accessory” set of genes. In this definition, the accessory set is believed to be a 
source of genetic variability allowing for niche adaptations, and is gained through lateral gene transfer 
[18], which is essentially the definition of the “dispensable” gene set noted above [15]. The notion of a 
core set of genes being necessary as a minimal set is important in the development of synthetic 
genomes, a biotechnology application of genome sequence data and bioinformatics. 




1.3. Biotechnological Applications and Viral Genomics 
The application of genomic and bioinformatic methodologies and technologies to virus studies is 
providing not only a large amount of data, but also is stimulating an increasing number of applications. 
As mentioned earlier, the genomes (Eaton et al., and Hendrickson et al.) and the tools used to mine 
data from them (Sadeque et al.), provide unique sequence signatures that may be used to populate 
microarray chips for surveillance and diagnostics [11,14] or to develop specific polymerase chain 
reaction (PCR) assays. A different application is realized in using these approaches to understand in 
greater detail the viruses that are used in biomedical and biotechnological processes, for example 
adenoviruses are used in human gene therapy as gene transfer vectors; genomics and bioinformatics 
allow for a rational approach to designing appropriate and safe vectors [19]. 
1.4. Development of Standards for Viral Genome and Annotation Data 
The emerging sets of viral genome data from both virus families and sporadic isolates are 
prompting a focused interest in establishing standards for consistent and comprehensive genome 
sequence annotation for viral genomes. The 3rd Prokaryotic Genome Annotation workshop was held 
on 26-27 April 2010 at the J. Craig Venter Institute (JCVI; Rockville, MD), sponsored by the National 
Center for Biotechnology Information (NCBI). For the first time, a virus genome Working Group was 
included, formed and tasked with developing sequence, function, and metadata annotation standards 
for viral and bacteriophage genomes. In this issue, Brister, et al. provide a meeting report to 
summarize the discussions and issues involved in establishing viral genome annotation standards the 
NCBI Annotation Workshop. In addition they also review the policy recommendations presented at 
this meeting. These are necessary, in light of the very large data set of virus genomes that is being 
generated by many researchers globally. As they noted, there are 27,091 full-length virus genomes 
deposited in GenBank as of 2010. In the context of the discussion earlier of the on-going recent 
NIAID-funded projects in the U.S., a significant increase of viral genomes is anticipated in the very 
near future. Standards and consistencies are vital for the archiving, distribution and use of these data, 
particularly since international research allows for the deposit of these sequences into one or more 
public databases: International Nucleotide Sequence Database Collaboration (INSDC), the DNA 
Database of Japan (DDBJ) [2], the European Nucleotide Archive (ENA) [3], and GenBank [4]. Since 
the individual data are the responsibility of the researcher, it is imperative for universal standards to be 
developed and to be imposed for data depositors to avoid “cacophony” and to allow stress-free 
effective data mining of these databases. 
2. Summary 
Viruses have been known and studied since before the start of the last century. Continued 
investigations of these “beings” over these many years despite the lack of high-resolution tools reflect 
the many important roles they play relative to humans. Our understanding of them and our ability to 
take advantage of them are limited by our lack of complete data, preferably high-resolution, and by the 
tools that are available. The relevant and important contributions in this special issue, along with the 




century, and with the continuing development of next generation DNA sequencing technology, 
highlight how genomics and bioinformatics are allowing and will allow a much deeper and broader 
understanding and appreciation of viruses and bacteriophages. As noted by Torres et al., we are on the 
cusp of a “revolution in viral genomics”. Alea iacta est! 
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